IRTC iRhythm Technologies Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRTC

Price (delayed)

$107.35

Market cap

$3.53B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.85

Enterprise value

$4.01B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 45

iRhythm is a leading digital health care company redefining the way cardiac arrhythmias are clinically diagnosed. The company combines wearable biosensor devices worn for up to 14 days and cloud-based ...

Highlights
IRTC's equity has surged by 86% year-on-year and by 6% since the previous quarter
The EPS has soared by 73% YoY and by 39% from the previous quarter
The quick ratio has contracted by 11% YoY but it has grown by 10% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.irhythmtech.com
Peers: MD

Key stats

What are the main financial stats of IRTC

IRTC stock price

How has the iRhythm Technologies stock price performed over time
Intraday
2.67%
1 week
-7.14%
1 month
-9.93%
1 year
-25.36%
YTD
-39.5%
QTD
-9.04%

Financial performance

How have iRhythm Technologies's revenue and profit performed over time
Revenue
$787.85M
Gross profit
$559.39M
Operating income
-$41.04M
Net income
-$27.78M
Gross margin
71%
Net margin
-3.5%
The net margin has soared by 78% YoY and by 42% from the previous quarter
The company's net income has surged by 72% YoY and by 38% QoQ
IRTC's operating margin has soared by 71% YoY and by 32% from the previous quarter
The operating income has soared by 63% YoY and by 29% from the previous quarter

Price vs fundamentals

How does IRTC's price correlate with its fundamentals

Growth

What is iRhythm Technologies's growth rate over time

Valuation

What is iRhythm Technologies stock price valuation
P/E
N/A
P/B
21.52
P/S
4.43
EV/EBIT
N/A
EV/EBITDA
318.24
EV/Sales
5.09
The EPS has soared by 73% YoY and by 39% from the previous quarter
IRTC's equity has surged by 86% year-on-year and by 6% since the previous quarter
IRTC's P/B is 46% below its last 4 quarters average of 38.5 and 11% below its 5-year quarterly average of 23.6
The P/S is 41% below the 5-year quarterly average of 7.3 and 38% below the last 4 quarters average of 7.0
The revenue has grown by 27% YoY and by 5% from the previous quarter

Efficiency

How efficient is iRhythm Technologies business performance
IRTC's return on invested capital has surged by 87% year-on-year and by 58% since the previous quarter
The ROS has soared by 87% YoY and by 56% from the previous quarter
iRhythm Technologies's ROE has soared by 82% YoY and by 46% from the previous quarter
The ROA has soared by 74% YoY and by 39% from the previous quarter

Dividends

What is IRTC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRTC.

Financial health

How did iRhythm Technologies financials performed over time
IRTC's total assets is 19% greater than its total liabilities
The current ratio has grown by 12% since the previous quarter but it has declined by 9% year-on-year
The quick ratio has contracted by 11% YoY but it has grown by 10% from the previous quarter
IRTC's equity has surged by 86% year-on-year and by 6% since the previous quarter
The debt to equity has contracted by 47% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.